blue cross glp 1 coverage Blue Shield of Mass. faces second year of record losses IBX members face GLP-1 drug

GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes when other medications havent sufficiently managed blood sugar levels

Ethics declarations Conflict of Interest MH has received consultant fees from Alkermes, Inc

However, evidence-based ballparks include: Patients taking Wegovy (a semaglutide) for up to 68 weeks lost up to 12.4% of initial body weight

As a result, semaglutides prescribing info advises caution and close monitoring in those with a history of diabetic eye disease

Cost-effectiveness evaluation: Given the relatively recent development and potential higher cost of GLP-1 RAs and SGLT2is compared to traditional treatments, such as metformin, evaluating the cost-effectiveness of various treatment options is crucial for prioritizing in healthcare settings

Int J Mol Med 41(5):24502460 Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML et al (2020) On-treatment decrease of serum interleukin-6 as a predictor of clinical response to biologic therapy in patients with inflammatory bowel diseases